Rejuvenation of nucleus pulposus cells using extracellular matrix deposited by synovium-derived stem cells. At each passage, cell numbers were counted for proliferation rate, cell phenotype was evaluated using flow cytometry, and cell differentiation status was ... F He,P Ming - 《Spine》 被引量:...
Alheim.Detection of complement‐fixing and non‐fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry[J]. Tissue Antigens .2012(5)Almahri,A.,Holgersson,J.,Alheim,M.. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor ...
‘Ca. A. thalassa’ is a diazotrophic taxon that lacks key metabolic pathways and lives in symbiosis with photosynthetic eukaryotic cells19,36. The high genomic similarity between ASW 00003 and the ‘Ca. A. thalassa’ genome sorted by flow cytometry demonstrates the accuracy of our metagenomic ...
S., Dupont, B., Hodes, M. Z., and Good, R. A., O’Reilly, R. J., 1983, Transplantation for severe combined immunodeficiency with HLA-A,B,C,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells,Blood61:341–348. ...
Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fixing reagents used in flow cytometry. J Immunol Methods. 1993;160:215- 218.Nicholson JK, Browning SW, Orloff SL, McDougal JS. Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fixing reagents...
Provided is a flow cytometry method and kit composition for semi-quantitatively determining complement fixing antibodies (CFAbs). The said antigen specific CFAbs in the sample will react with the antigens on the solid carriers or the surfaces of target cells as well as the labeled complement or...
The final cells were acquired and analyzed on a Canto-II flow cytometer. The fluorescence intensities of PE and FITC were proportionately correlated to the concentrations of CFAbs and IgG bound respectively on the T and B cells. IgG-FXM: Regular flow cytometry XM procedure. Microcytotoxicity ...
Antibody-based immunotherapy has been proposed for the treatment of PDAC, but its efficacy has so far proved limited. The proteoglycan glypican-1 (GPC1) may be a useful immunotherapeutic target because it is highly expressed on the surface of PDAC cells, whereas it is not expressed or is ...
Based on the clinical relevance of CDC, we have successfully developed a new Flow Cytometry C1q crossmatch (C1q-FXM) to specifically detect Donor PBMCs (0.1x 106) were incubated with 30 ul serum and CD3-PerCPCy5.5, CD19-FITC and SAPE-Bio-C1q for 30 minutes. After washing, the cells ...